PHC COVID-19 Rapid Antigen Test Kit Approved for Sale in Australia
[Asia Economy Reporter Chunhee Lee] PHC's COVID-19 rapid antigen test kit is entering the Australian market.
PHC announced on the 14th that its affiliate, PhiloSys, received approval from the Australian Therapeutic Goods Administration (TGA) to sell its COVID-19 rapid diagnostic product for self-testing.
The approved product, 'Gmate COVID-19 Ag,' uses a saliva-based diagnostic method, boasting a sensitivity of over 95% and management capabilities through an application (app). The saliva diagnostic method minimizes discomfort for the test subject compared to the conventional nasopharyngeal swab method, reduces the risk of infection, and allows the test subject to easily collect and verify the specimen without the assistance of medical professionals.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- The Unexpected Story of an American Man Who Won the Lottery 18 Times in 29 Years: "My Real Luck Is My Wife"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
A PHC representative explained, "By obtaining approval in Australia, the product's performance and quality system have been recognized to the extent that regulatory procedures can be simplified when entering other countries."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
